drugset / Trial / NCT00311350
Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects
RandomizedDouble-blind
Summary
This is the first multiple-dose experience in humans with MOA-728 in an oral formulation. This study will provide an assessment of the safety, tolerability, and pharmacokinetics (PK) of MOA-728 following administration of ascending multiple oral doses to healthy subjects.
Timeline
- Start
- 2006-03
- Primary completion
- —
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylnaltrexone | Other / unclassified | — | Oral |